Acceder

K-V Pharmaceutical Co. Opiniones

2,2K respuestas
K-V Pharmaceutical Co. Opiniones
K-V Pharmaceutical Co. Opiniones
Página
108 / 277
#857

Re: K-V Pharmaceutical Co. Opiniones

que piensan para hoy

#858

Re: K-V Pharmaceutical Co. Opiniones

Off topic: BMSN, otra orphan drug.
Anyone with an eye on Penny Stocks in recent weeks has seen the spectacular rise of Bio-Matrix Scientific Group, Inc. (OTC: BMSN) from triple zero 2's to recent highs of well over a Penny. As the stock continues to trade massive volume many investors are speculating this one goes way higher from current levels.
All the excitement is about HemaXellerate I™ BMSN's subsidiary Regen BioPharma new stem cell drug to combat Aplastic Anemia. The Company has submitted an Investigational New Drug (IND) Application to the FDA several weeks ago and things are looking on the up and up.
HemaXellerate I™ BMSN’s stem cell drug to combat Aplastic Anemia is eligible for Orphan Drug Status which makes HemaXellerate I™ able to get full FDA approval in as little as 60 days to bypass the lengthy Phase I, II, III, IV FDA Approval Processes because of being eligible for Orphan Drug Status.
Judging that the potential market share for the Companies new drugs are well over US $10 billion even if BMSN were able to achieve a small market share, this little biotechnology Company that trades on the bb's with a total market valuation of several million dollars could represent a spectacular trade opportunity for smart early investors.
Penny Stock Speculators should be warned however that stories as juicy as this one do come around quite often on the sub exchanges and most of the time it’s all fluff or outright lies and does not bode well for investors.
Conclusion: BMSN has made an explosive move up as investors wait un news from the Food and Drug Administration (FDA) While HemaXellerate I™ could mean huge gains for investors it could just as easily go nowhere and leave investors holding the bag.

entrada el viernes nuevamente a 0,28. Stop a 0,24

Por cierto: en pre KV a 0,36.
Tarde o temprano ha cerrar el gap entre 0,25 y 0,30.
Si hay caida, entrada a 0,25 seria interesante (y muy afortunada)

edito: es KVPBK en 0,36. Presagio?

#859

Re: K-V Pharmaceutical Co. Opiniones

esta con baja casi en 0.44 a ver cuando retrocede para que suba

#860

Re: K-V Pharmaceutical Co. Opiniones

ya esta en 0.41 poco volumen

#861

Re: K-V Pharmaceutical Co. Opiniones

mejoro algo en 0.42 compra venta en 0.44

#862

Re: K-V Pharmaceutical Co. Opiniones

Que quieto anda esto, a espera del miercoles?

#863

Re: K-V Pharmaceutical Co. Opiniones

la ultima hora movera al menos eso pienso

#864

Re: K-V Pharmaceutical Co. Opiniones

Tiene buena pinta BMSN

Te puede interesar...
  1. Primeras dudas sobre la 'Trumponomics', ¿corrección o toma de beneficios?